User profiles for Javier Gomez-Román

Gomez-Roman, Javier

Pathology Service. Hospital Universitario Marques de Valdecilla. Universidad de Cantabria …
Verified email at alumni.unav.es
Cited by 3706

Actualización de las recomendaciones para la determinación de biomarcadores en el carcinoma de pulmón avanzado de célula no pequeña. Consenso Nacional de …

…, Á Concha, P Garrido, J Gómez-Román… - Revista Española de …, 2015 - Elsevier
En el año 2011 se inició un proyecto conjunto entre la Sociedad Española de Oncología
Médica (SEOM) y la Sociedad Española de Anatomía Patológica (SEAP) para establecer unas …

Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer

…, GJ Heynen, DAM Heideman, J Gomez-Roman… - Cancer discovery, 2014 - AACR
Activating mutations in the EGF receptor (EGFR) are associated with clinical responsiveness
to EGFR tyrosine kinase inhibitors (TKI), such as erlotinib and gefitinib. However, resistance …

[HTML][HTML] Nueva actualización de las recomendaciones para la determinación de biomarcadores predictivos en el carcinoma de pulmón no célula pequeña: Consenso …

…, J de Castro, E Conde, E Felip, J Gómez-Román… - Revista Española de …, 2023 - Elsevier
El carcinoma de pulmón de no célula pequeña (CPNCP) presenta el mayor número de dianas
terapéuticas identificadas, algunas de ellas con utilidad terapéutica. En la actualidad se …

[HTML][HTML] New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and …

…, E Conde, E Felip, J Gómez-Román… - Clinical and …, 2023 - Springer
Non-small cell lung cancer (NSCLC) presents the greatest number of identified therapeutic
targets, some of which have therapeutic utility. Currently, detecting EGFR, BRAF, KRAS and …

[HTML][HTML] Accurate Identification of ALK Positive Lung Carcinoma Patients: Novel FDA-Cleared Automated Fluorescence In Situ Hybridization Scanning System and …

…, J Sanz, V Folgueras, N Villanueva, J Gomez-Roman… - PLoS …, 2014 - journals.plos.org
Background Based on the excellent results of the clinical trials with ALK-inhibitors, the
importance of accurately identifying ALK positive lung cancer has never been greater. However, …

[HTML][HTML] 26Postoperative diagnosis and outcome in patients with revision arthroplasty for aseptic loosening

…, M Fakkas-Fernandez, J Gómez-Román… - BMC infectious …, 2015 - Springer
Background The most common cause of implant failure is aseptic loosening (AL), followed
by prosthetic joint infection (PJI). This study evaluates the incidence of PJI among patients …

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

…, C Morales Torres, P Scaffidi, J Gomez-Roman… - Oncogene, 2021 - nature.com
The survival rate in lung cancer remains stubbornly low and there is an urgent need for the
identification of new therapeutic targets. In the last decade, several members of the SWI/SNF …

Collagen, type XI, alpha 1: an accurate marker for differential diagnosis of breast carcinoma invasiveness in core needle biopsies

…, A De Juan, A Vega, L Simón, J Gómez-Román - … -Research and Practice, 2014 - Elsevier
… Author links open overlay panel Javier Freire a b , Saioa Domínguez-Hormaetxe d , Saray
Pereda a b c , Ana De Juan e , Alfonso Vega f , Laureano Simón d , Javier Gómez-Román a b …

[PDF][PDF] La autopsia clínica

FPA Mateos, FÁ Fernández, MM Fernández… - Revista Electrónica de …, 2009 - seap.es
Antecedentes: La autopsia clínica tiene unos 2000 años de historia. Su período dorado, sin
embargo, lo forman los últimos 150 años, en que ha contribuido de forma sustancial al …

[HTML][HTML] Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer

…, MJ Pajares, V Segura, E Guruceaga, J Gomez-Roman… - 2012 - journals.plos.org
Lung cancer is a leading cause of cancer death worldwide. Several alterations in RNA
metabolism have been found in lung cancer cells; this suggests that RNA metabolism-related …